InvestorsHub Logo
icon url

jimtash

05/20/14 8:06 AM

#22569 RE: runncoach #22567

Exactly. Who cares that they registered the new website on the same day? It's not like Radient Diagnostics is a hard to acquire domain name or that they need to start work ASAP on new websites and gear up for a new campaign. Especially if they plan on going dark for any length of time.
icon url

Gold Seeker

05/20/14 8:06 AM

#22570 RE: runncoach #22567

Runcoach, I agree. There is nothing about a website that says the stock is not going to be revoked. There is just no way the Aussies can get the filings up to date to prevent the stock registration from being revoked. Even if they give an alternate plan to the law Judge, they still have to come up with the audited filings that cost money. Who is going to do that. All the old management is gone. How is anyone going to come up with acceptable SEC filings?

Where is the money? Maybe Charter can invent another already invented product?
icon url

SubPennyDude

05/21/14 11:23 AM

#22614 RE: runncoach #22567

This has always been my opinion. MGMT will restructure simply because they do have a product. Maybe that product has a low probability of success but at least it has some success record. This success record could be easily amplified by a take over from another larger phrama. I think it is clear how the pharma industry is going through a lot of change lately with all the aquisitons and cancer is at the heart of what pharma companies are trying to position themselves.
of course no one will take over with ~5B in outstanding hence the request for SEC to revok shares. Furthermore, the 30 something million in debt is simply a joke for a pharma company with a product even in the case of RXPC.
bottom line, this will restructure and make MGMT money along with whoever takes over the ownership. As far as retail shareholdes, they are kinda screwed with that SEC filing.